|
The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF |
Min Y J, Kim S W, Suh C, Park J, Kim H J, Kim J G, Kim T W, Lee J H, Kim S B, Lee K H, Lee J S, Kim W K, Kim S H |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Min Y J, Kim S W, Suh C, Park J, Kim H J, Kim J G, Kim T W, Lee J H, Kim S B, Lee K H, Lee J S, Kim W K, Kim S H. The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF. Journal of Korean Medical Science 2000; 15(1): 49-52 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Antigens, CD34 /immunology /metabolism; Antineoplastic Agents, Alkylating /adverse effects /therapeutic use; Breast Neoplasms /therapy; Cost-Benefit Analysis; Cyclophosphamide /adverse effects /therapeutic use; Drug Administration Schedule; Female; Graft Survival; Granulocyte Colony-Stimulating Factor /adverse effects /therapeutic use; Hematopoietic Stem Cell Mobilization /adverse effects /economics /methods; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells /immunology /metabolism; Humans; Lymphoma, Non-Hodgkin /therapy; Male; Middle Aged; Multiple Myeloma /therapy; Sarcoma, Ewing /therapy AccessionNumber 22000000481 Date bibliographic record published 03/04/2000 |
|
|
|